Company overview
eKare provides digital wound imaging and measurement technology through its inSight platform. Founded in 2014 as a spin-off from Children’s National Medical Center, the company combines mobile imaging, wound documentation, workflow tools and analytics for care providers and clinical research organizations.
The company lists its U.S. address in Fairfax, Virginia, alongside a European business in the Netherlands. Patrick Cheng is CEO and co-founder, with Kyle Wu serving as Chief Medical Officer. The product is offered commercially for clinical practice and research workflows.
Company support materials identify inSight as FDA registered under product code FXN, while FDA classification describes the surgical-camera category as 510(k) exempt. This is not a verified 510(k) clearance of every AI feature, diagnostic claim or later software configuration. Product-version and intended-use mapping remain important research boundaries.
[3][4][5][7]